Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion (Q38751649)

6 September 2017

Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion (English)

1 reference

6 September 2017

1 reference

1 reference

13

1 reference

6 September 2017

Olca Basturk

5

0 references

Eva Hernando

object named as

Eva Hernando

10

0 references

Angel Pellicer

object named as

Angel Pellicer

11

0 references

author name string

Jian-Jun Wei

1

1 reference

6 September 2017

Xinyu Wu

2

1 reference

6 September 2017

Yi Peng

3

1 reference

6 September 2017

Guizhi Shi

4

1 reference

6 September 2017

Ximing Yang

6

1 reference

6 September 2017

Garrett Daniels

7

1 reference

6 September 2017

Iman Osman

8

1 reference

6 September 2017

Jiangyong Ouyang

9

1 reference

6 September 2017

Johng S Rhim

12

1 reference

6 September 2017

Peng Lee

14

1 reference

6 September 2017

language of work or name

English

0 references

publication date

7 December 2010

1 reference

6 September 2017

Clinical Cancer Research

1 reference

6 September 2017

17

1 reference

6 September 2017

6

1 reference

6 September 2017

1297-1305

1 reference

LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Widespread deregulation of microRNA expression in human prostate cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

MicroRNAs and chromosomal abnormalities in cancer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

A microRNA expression signature of human solid tumors defines cancer gene targets

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Substrate requirements for let-7 function in the developing zebrafish embryo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

MicroRNA expression profiling in prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Extensive expression studies revealed a complex alternative splicing pattern of the HMGA2 gene

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Differential HMGA expression and post-translational modifications in prostatic tumor cells.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Loss of mir-146a function in hormone-refractory prostate cancer

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

High level expression of the HMGI (Y) gene during embryonic development.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196617

High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells

23 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21138859

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21138859

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-10-0993

1 reference

6 September 2017

1 reference

6 September 2017

1 reference